| healthcare |
Ministry launches diabetes awareness event
November 18, 2019
Manama, Nov. 17 (BNA): The Ministry of Health (MoH) announced that it would launch on Monday, November 18 its '1,000-tweet' health awareness campaign in cooperation with the National Committee for Combating Incommunicable Diseases. The activity marks the World Health Organization (WHO)†s celebration of the World Diabetes Day this year themed 'Diabetes"...
Interim analysis from EMPRISE real-world study shows empagliflozin decreased risk of hospitalisation for heart failure compared with DPP-4 inhibitors and GLP-1 receptor agonists
November 18, 2019
A new interim analysis of three-year data from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) real-world study on effectiveness shows that empagliflozin was associated with a decreased risk of hospitalisation for heart failure and a similar risk of non-fatal atherosclerotic cardiovascular events compared with DPP-4 inhibitors and GLP-1 receptor agonists.1 The interim analysis included 190,000 adults in the US with type 2 diabetes with and without cardiovascular disease. The results were shared today on behalf"...
Bahrain Dental Conference & Exhibition kicks off
November 17, 2019
The Fourth Bahrain Dental Conference & Exhibition “DLS4 Bahrain” kicked off today (November 14) under the patronage of Lieutenant General Doctor Sheikh Mohammed bin Abdullah Al Khalifa, president of the Supreme Council for Health. Organised by the BDA Center for Medical and Scientific Events, it will run till November 16 at the Art Rotana Hotel. ...
Southern Governor launched health programme
November 16, 2019
Manama, Nov.14 (BNA): Southern Governor His Highness Shaikh Khalifa bin Ali bin Khalifa Al-Khalifa has today inaugurated a programme aimed at combating diabetes. The event was attended by Supreme Council for Health (SCH) President Lieuetant-General Dr. Shaikh Mohammed bin Abdulla Al-Khalifa, Health Minister Faeqa bint Said Al-Saleh and other senior officials. ...
Under the patronage and in the presence of H.E. Sheikh Dr. Saeed bin Tahnoun Al Nahyan unveils 17th clinic of CosmeSurge
November 16, 2019
H.E. Sheikh Dr Saeed bin Tahnoun Al Nahyan, inaugurated CosmeSurge’s 17th clinic. With clinics across UAE and Oman, CosmeSurge is one of the region’s most trusted brands for cosmetic and aesthetic procedures. The new clinic opened in Zakher, Al Ain, will offer unique and specialist treatments that will redefine your beauty. NMC Healthcare's Director of Corporate Operations Strategy Clancey Po launched the latest facility, which will"...
National Health Regulatory Authority is partner in “DLS4 Bahrain”
November 14, 2019
International Dental Conference & Exhibition “DLS4 Bahrain” will be held in partnership with the National Health Regulatory Authority from November 14 to 16 at the Art Rotana Hotel. The conference will be opened by H.E. Dr. Mariam Al-Jalahma, Chairman of the National Health Regulatory Authority, who will discuss investment in the health sector and the necessity to keep up with the latest scientific developments in this field, in"...
Takeda Announces 12 New Molecular Entities with the Potential for 14 Launches in the Next Five Years at 2019 R&D Day
November 14, 2019
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) will host an R&D meeting today beginning at 12:30 p.m. EST in New York City to outline how its science-first, patient-centric strategy, diverse portfolio of approved medicines and its R&D engine is expected to drive the company’s near-term and sustained growth. In the near-term, Takeda expects that its 14 current global growth brands will generate significant momentum enabled by at least 20 additional indications and major market expansions through FY24. In the same time period, the organization anticipates delivering 12 new molecular entities with the potential for 14 launches, representing best-in-class or first-in-class therapies across its core areas of focus. Looking ahead to FY25 and beyond, Takeda’s transformative R&D engine comprising internal research capabilities and external......
Boehringer Ingelheim and Lilly initiate first ever study to assess empagliflozin in people hospitalised for acute heart failure who have been stabilised
November 12, 2019
Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced the initiation of EMPULSE, the sixth Phase III study in the empagliflozin heart failure programme. The study will assess whether in-hospital administration of empagliflozin 10 mg daily improves heart failure outcomes when initiated in people hospitalised for any type of acute heart failure event once they have been stabilised. The study will include participants both with and without type 2 diabetes. This"...
Fourth edition of Bahrain International Dental Conference & Exhibition
November 11, 2019
Under the patronage of His Excellency Lieutenant General Doctor Shaikh Mohammed bin Abdullah Al Khalifa, Chairman of the Supreme Council of Health, “BDA” center will organize the fourth edition of Bahrain International Dental Conference & Exhibition“DlS4 Bahrain 2019” at the Art Rotana Hotel on November 14 and lasts for three days. This year, the conference includes 12 workshops with 40 participants, and it is expected"...
Mary Kay Continues Its Commitment to Advance Skin Science Research at the Japanese Society of Investigative Dermatology
November 11, 2019
As a leader in skincare innovation worldwide, Mary Kay Inc. continued its commitment to advance skin science as a symposium sponsor at the 44th annual meeting of The Japanese Society of Investigative Dermatology (JSID). At the conference held Nov. 8 - 10 in Aomori, Japan, the symposium on skin barriers and skin redness provided a collaborative environment to share technological advances and breakthroughs on skin health. Established in 1981, the"...
|
|
|
|
|
